Eight out of ten young adults with dangerously elevated blood pressure have never been told they have it.

That's not a rounding error or a data artifact. Among adults aged 18–29 whose measured blood pressure meets hypertension criteria, 86.7% of females and 81.8% of males report never receiving a diagnosis. These are people with blood pressure readings that qualify as hypertension, walking out of whatever clinical encounters they do have without any flag on their chart.

The contrast with older adults is stark. Among adults 70 and older with measured hypertension, only 27.4% of females and 35.9% of males remain unaware of their condition. Decades of accumulated doctor visits, routine screenings, and age-related health vigilance close most of that gap. But the damage from uncontrolled hypertension accumulates over time, and the years between 18 and 70 are exactly when that accumulation happens.

Young Adults Are Carrying the Largest Diagnostic Gap

The awareness gap doesn't close quickly with age. Among adults 30–39 with measured hypertension, 61.6% of females and 77.2% of males still haven't been diagnosed. By ages 50–59, 50.3% of females and 45.3% of males remain undiagnosed. That's a majority of middle-aged adults with elevated blood pressure who have no idea.

For context: Stage 2 hypertension (systolic at or above 140, diastolic at or above 90) carries meaningful cardiovascular risk. Every year that passes without treatment is a year of arterial stress that doesn't reverse when a diagnosis finally arrives. The 18–29 cohort isn't just undiagnosed today. They're accumulating risk that will show up in cardiovascular event rates a decade or two from now.

The gender pattern across age groups is also consistent. Males tend to have slightly higher unawareness rates than females in younger cohorts, though the gap narrows considerably by the 60s. By ages 60–69, the rates are nearly identical: 44.0% of females and 44.2% of males remain undiagnosed. Whatever screening advantages females may have in younger adulthood, they don't translate into dramatically better outcomes at the population level.

The Highest-Income Group Dominates Undiagnosed Stage 2 Cases

Here's the number that complicates the standard narrative about healthcare access and diagnosis: Non-Hispanic White adults in the highest income quartile represent 29.0% of all undiagnosed Stage 2 hypertension cases, an estimated 4.27 million people.

Non-Hispanic White adults across all income quartiles account for a combined 60.9% of undiagnosed Stage 2 cases. The single largest slice of that total sits at the top of the income distribution, among people who presumably have the fewest structural barriers to care.

For comparison, Non-Hispanic Black adults in the highest income quartile represent 3.7% of undiagnosed Stage 2 cases (approximately 0.55 million people). Mexican American adults below the poverty line account for 1.7% (approximately 0.24 million people). These are real populations with real unmet need, but in raw numbers, the undiagnosed hypertension burden is concentrated in a demographic that doesn't fit the typical framing of the access problem.

This matters for how health systems think about screening. If undiagnosed hypertension were primarily a function of poverty or lack of insurance, the solution set would look one way. But 4.27 million higher-income Non-Hispanic White adults with Stage 2 hypertension and no diagnosis suggests something else is operating: perhaps infrequent primary care visits among people who feel healthy, perhaps clinical encounters that don't include blood pressure measurement, perhaps patients who decline follow-up on borderline readings.

The question the data raises but can't answer is what, exactly, is failing for that 29.0%. Higher income doesn't guarantee more engaged healthcare use, and a single blood pressure reading in a clinical setting doesn't always trigger the kind of follow-up that produces a formal diagnosis. But given that this group represents the largest single subgroup of undiagnosed Stage 2 hypertension in the country, the assumption that access alone drives the detection gap deserves serious scrutiny.